Heidelberg (pta014/25.02.2022/11:15) - 2invest AG (Frankfurt: 2INV; ISIN: DE000A3H3L44) has closed its financial year 2021 (01.01.2021 to 31.12.2021) with an expected net loss (individual financial statements according to HGB) in the amount of EUR 1.7 million and with available liquid funds (consisting of cash and bank balances plus liquid securities) in the amount of EUR 37.8 million as of 31 December 2021.
At the beginning of 2021, 2invest AG completed the transition from a functional and management holding company of a group of companies operating in the life sciences sector to an investment company. In this respect, the previous year's figures of the income statement of the company then operating under the name 4basebio AG, Heidelberg, are not comparable with the current 2invest AG. Therefore, no comparison with the previous year's figures is provided.
The preliminary result for the year includes other operating income in the amount of 2,267 TEUR, consisting mainly of sales of marketable securities (1,676 TEUR) and write-ups on marketable securities (213 TEUR) as well as personnel expenses in the amount of 158 TEUR, other operating expenses in the amount of 1,081 TEUR, depreciation in the amount of 14 TEUR and a financial result in the amount of -2,737 TEUR.
Other operating expenses mainly include legal and consulting costs (260 TEUR), capital market communication costs (141 TEUR), accounting and auditing costs (122 TEUR), foreign exchange losses (216 TEUR) and custody fees (137 TEUR).
The financial result in the amount of -2,737 TEUR is mainly composed of write-downs on marketable securities (3,626 TEUR) and other interest and similar income (889 TEUR).
The preliminary balance sheet as of 31 December 2021 in accordance with the German Commercial Code (HGB) shows equity in the amount of 82,778 TEUR (31.December 2020: 84,501 TEUR).
The aforementioned preliminary result is based on the preliminary valuation of the past financial year 2021 made by the Management Board on 25th of February 2022. The figures stated in this announcement are subject to the final preparation of the annual financial statements, the audit of the financial statements and the approval of the annual financial statements by the Supervisory Board.(end)
Ziegelhäuser Landstr. 3
|contact person:||Hansjörg Plaggemars|
|phone:||+49 6221 649 2480|
|stock exchanges:||regulated market in Frankfurt; free market in Dusseldorf, free market in Hamburg, free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate|